nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethionamide—Neurotoxicity—Gemcitabine—pancreatic cancer	0.031	0.031	CcSEcCtD
Ethionamide—Optic neuritis—Tamoxifen—pancreatic cancer	0.0284	0.0284	CcSEcCtD
Ethionamide—Hypothyroidism—Sunitinib—pancreatic cancer	0.0233	0.0233	CcSEcCtD
Ethionamide—Neurotoxicity—Docetaxel—pancreatic cancer	0.022	0.022	CcSEcCtD
Ethionamide—Neuritis—Gemcitabine—pancreatic cancer	0.0161	0.0161	CcSEcCtD
Ethionamide—Neurotoxicity—Epirubicin—pancreatic cancer	0.0148	0.0148	CcSEcCtD
Ethionamide—Neurotoxicity—Doxorubicin—pancreatic cancer	0.0137	0.0137	CcSEcCtD
Ethionamide—Salivary hypersecretion—Irinotecan—pancreatic cancer	0.012	0.012	CcSEcCtD
Ethionamide—Neuritis—Docetaxel—pancreatic cancer	0.0114	0.0114	CcSEcCtD
Ethionamide—Hypoglycaemia—Sunitinib—pancreatic cancer	0.0111	0.0111	CcSEcCtD
Ethionamide—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.0101	0.0101	CcSEcCtD
Ethionamide—Weight decreased—Tamoxifen—pancreatic cancer	0.00993	0.00993	CcSEcCtD
Ethionamide—Weight decreased—Erlotinib—pancreatic cancer	0.00982	0.00982	CcSEcCtD
Ethionamide—Photosensitivity—Fluorouracil—pancreatic cancer	0.00977	0.00977	CcSEcCtD
Ethionamide—Depression—Tamoxifen—pancreatic cancer	0.00975	0.00975	CcSEcCtD
Ethionamide—Depression—Erlotinib—pancreatic cancer	0.00965	0.00965	CcSEcCtD
Ethionamide—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00949	0.00949	CcSEcCtD
Ethionamide—Stomatitis—Erlotinib—pancreatic cancer	0.00943	0.00943	CcSEcCtD
Ethionamide—Optic neuritis—Epirubicin—pancreatic cancer	0.00935	0.00935	CcSEcCtD
Ethionamide—Hepatitis—Tamoxifen—pancreatic cancer	0.00878	0.00878	CcSEcCtD
Ethionamide—Hepatitis—Erlotinib—pancreatic cancer	0.00869	0.00869	CcSEcCtD
Ethionamide—Optic neuritis—Doxorubicin—pancreatic cancer	0.00865	0.00865	CcSEcCtD
Ethionamide—Weight decreased—Sunitinib—pancreatic cancer	0.0085	0.0085	CcSEcCtD
Ethionamide—Depression—Sunitinib—pancreatic cancer	0.00836	0.00836	CcSEcCtD
Ethionamide—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.00821	0.00821	CcSEcCtD
Ethionamide—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00818	0.00818	CcSEcCtD
Ethionamide—Stomatitis—Sunitinib—pancreatic cancer	0.00817	0.00817	CcSEcCtD
Ethionamide—Neuritis—Epirubicin—pancreatic cancer	0.00771	0.00771	CcSEcCtD
Ethionamide—Hepatitis—Sunitinib—pancreatic cancer	0.00752	0.00752	CcSEcCtD
Ethionamide—Dysgeusia—Tamoxifen—pancreatic cancer	0.00749	0.00749	CcSEcCtD
Ethionamide—Neuritis—Doxorubicin—pancreatic cancer	0.00713	0.00713	CcSEcCtD
Ethionamide—Weight decreased—Irinotecan—pancreatic cancer	0.007	0.007	CcSEcCtD
Ethionamide—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00677	0.00677	CcSEcCtD
Ethionamide—Stomatitis—Irinotecan—pancreatic cancer	0.00673	0.00673	CcSEcCtD
Ethionamide—Jaundice—Irinotecan—pancreatic cancer	0.00673	0.00673	CcSEcCtD
Ethionamide—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.00659	0.00659	CcSEcCtD
Ethionamide—Stomatitis—Gemcitabine—pancreatic cancer	0.00655	0.00655	CcSEcCtD
Ethionamide—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00648	0.00648	CcSEcCtD
Ethionamide—Stomatitis—Fluorouracil—pancreatic cancer	0.00644	0.00644	CcSEcCtD
Ethionamide—Dysgeusia—Sunitinib—pancreatic cancer	0.00641	0.00641	CcSEcCtD
Ethionamide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00611	0.00611	CcSEcCtD
Ethionamide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00604	0.00604	CcSEcCtD
Ethionamide—Anorexia—Tamoxifen—pancreatic cancer	0.00595	0.00595	CcSEcCtD
Ethionamide—Anorexia—Erlotinib—pancreatic cancer	0.00588	0.00588	CcSEcCtD
Ethionamide—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00565	0.00565	CcSEcCtD
Ethionamide—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00559	0.00559	CcSEcCtD
Ethionamide—Dyspepsia—Tamoxifen—pancreatic cancer	0.00549	0.00549	CcSEcCtD
Ethionamide—Dyspepsia—Erlotinib—pancreatic cancer	0.00543	0.00543	CcSEcCtD
Ethionamide—Decreased appetite—Tamoxifen—pancreatic cancer	0.00542	0.00542	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00539	0.00539	CcSEcCtD
Ethionamide—Decreased appetite—Erlotinib—pancreatic cancer	0.00537	0.00537	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00533	0.00533	CcSEcCtD
Ethionamide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00523	0.00523	CcSEcCtD
Ethionamide—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.00517	0.00517	CcSEcCtD
Ethionamide—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.0051	0.0051	CcSEcCtD
Ethionamide—Anorexia—Sunitinib—pancreatic cancer	0.00509	0.00509	CcSEcCtD
Ethionamide—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00505	0.00505	CcSEcCtD
Ethionamide—Abdominal pain—Tamoxifen—pancreatic cancer	0.00493	0.00493	CcSEcCtD
Ethionamide—Abdominal pain—Erlotinib—pancreatic cancer	0.00488	0.00488	CcSEcCtD
Ethionamide—Vision blurred—Fluorouracil—pancreatic cancer	0.00487	0.00487	CcSEcCtD
Ethionamide—Weight decreased—Docetaxel—pancreatic cancer	0.00484	0.00484	CcSEcCtD
Ethionamide—Photosensitivity—Epirubicin—pancreatic cancer	0.00476	0.00476	CcSEcCtD
Ethionamide—Dyspepsia—Sunitinib—pancreatic cancer	0.0047	0.0047	CcSEcCtD
Ethionamide—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.00468	0.00468	CcSEcCtD
Ethionamide—Vascular purpura—Epirubicin—pancreatic cancer	0.00467	0.00467	CcSEcCtD
Ethionamide—Stomatitis—Docetaxel—pancreatic cancer	0.00465	0.00465	CcSEcCtD
Ethionamide—Jaundice—Docetaxel—pancreatic cancer	0.00465	0.00465	CcSEcCtD
Ethionamide—Decreased appetite—Sunitinib—pancreatic cancer	0.00465	0.00465	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00461	0.00461	CcSEcCtD
Ethionamide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.0046	0.0046	CcSEcCtD
Ethionamide—Photosensitivity—Doxorubicin—pancreatic cancer	0.0044	0.0044	CcSEcCtD
Ethionamide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00437	0.00437	CcSEcCtD
Ethionamide—Purpura—Epirubicin—pancreatic cancer	0.00433	0.00433	CcSEcCtD
Ethionamide—Vascular purpura—Doxorubicin—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Ethionamide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00431	0.00431	CcSEcCtD
Ethionamide—Hepatitis—Docetaxel—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Ethionamide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00428	0.00428	CcSEcCtD
Ethionamide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Ethionamide—Abdominal pain—Sunitinib—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Ethionamide—Diarrhoea—Erlotinib—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Ethionamide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.0042	0.0042	CcSEcCtD
Ethionamide—Anorexia—Irinotecan—pancreatic cancer	0.0042	0.0042	CcSEcCtD
Ethionamide—Diplopia—Epirubicin—pancreatic cancer	0.00418	0.00418	CcSEcCtD
Ethionamide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Ethionamide—Dizziness—Tamoxifen—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Ethionamide—Anorexia—Gemcitabine—pancreatic cancer	0.00409	0.00409	CcSEcCtD
Ethionamide—Dizziness—Erlotinib—pancreatic cancer	0.00408	0.00408	CcSEcCtD
Ethionamide—Anorexia—Fluorouracil—pancreatic cancer	0.00402	0.00402	CcSEcCtD
Ethionamide—Purpura—Doxorubicin—pancreatic cancer	0.00401	0.00401	CcSEcCtD
Ethionamide—Vomiting—Tamoxifen—pancreatic cancer	0.00397	0.00397	CcSEcCtD
Ethionamide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Ethionamide—Hypersensitivity—Sunitinib—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Ethionamide—Rash—Tamoxifen—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Ethionamide—Dermatitis—Tamoxifen—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Ethionamide—Vomiting—Erlotinib—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Ethionamide—Somnolence—Irinotecan—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Ethionamide—Headache—Tamoxifen—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Ethionamide—Rash—Erlotinib—pancreatic cancer	0.00389	0.00389	CcSEcCtD
Ethionamide—Dermatitis—Erlotinib—pancreatic cancer	0.00389	0.00389	CcSEcCtD
Ethionamide—Dyspepsia—Irinotecan—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Ethionamide—Headache—Erlotinib—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Ethionamide—Diplopia—Doxorubicin—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Ethionamide—Decreased appetite—Irinotecan—pancreatic cancer	0.00383	0.00383	CcSEcCtD
Ethionamide—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Ethionamide—Somnolence—Gemcitabine—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.0038	0.0038	CcSEcCtD
Ethionamide—Somnolence—Fluorouracil—pancreatic cancer	0.00375	0.00375	CcSEcCtD
Ethionamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00373	0.00373	CcSEcCtD
Ethionamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Ethionamide—Nausea—Tamoxifen—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0037	0.0037	CcSEcCtD
Ethionamide—Nausea—Erlotinib—pancreatic cancer	0.00367	0.00367	CcSEcCtD
Ethionamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.00367	0.00367	CcSEcCtD
Ethionamide—Diarrhoea—Sunitinib—pancreatic cancer	0.00366	0.00366	CcSEcCtD
Ethionamide—Dysgeusia—Docetaxel—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00364	0.00364	CcSEcCtD
Ethionamide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Ethionamide—Dizziness—Sunitinib—pancreatic cancer	0.00353	0.00353	CcSEcCtD
Ethionamide—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00353	0.00353	CcSEcCtD
Ethionamide—Abdominal pain—Irinotecan—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Ethionamide—Vomiting—Sunitinib—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Ethionamide—Rash—Sunitinib—pancreatic cancer	0.00337	0.00337	CcSEcCtD
Ethionamide—Dermatitis—Sunitinib—pancreatic cancer	0.00337	0.00337	CcSEcCtD
Ethionamide—Headache—Sunitinib—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Ethionamide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00329	0.00329	CcSEcCtD
Ethionamide—Weight decreased—Epirubicin—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Ethionamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00324	0.00324	CcSEcCtD
Ethionamide—Drowsiness—Epirubicin—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Ethionamide—Nausea—Sunitinib—pancreatic cancer	0.00317	0.00317	CcSEcCtD
Ethionamide—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Ethionamide—Stomatitis—Epirubicin—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ethionamide—Jaundice—Epirubicin—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Ethionamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Ethionamide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Ethionamide—Weight decreased—Doxorubicin—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Ethionamide—Diarrhoea—Irinotecan—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Ethionamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Ethionamide—Drowsiness—Doxorubicin—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Ethionamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Ethionamide—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Ethionamide—Dizziness—Irinotecan—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Ethionamide—Stomatitis—Doxorubicin—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Ethionamide—Jaundice—Doxorubicin—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Ethionamide—Anorexia—Docetaxel—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Ethionamide—Hepatitis—Epirubicin—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Ethionamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Ethionamide—Vomiting—Irinotecan—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Ethionamide—Dizziness—Fluorouracil—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Ethionamide—Rash—Irinotecan—pancreatic cancer	0.00278	0.00278	CcSEcCtD
Ethionamide—Dermatitis—Irinotecan—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Ethionamide—Headache—Irinotecan—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Ethionamide—Vomiting—Gemcitabine—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Ethionamide—Somnolence—Docetaxel—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Ethionamide—Rash—Gemcitabine—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Ethionamide—Dermatitis—Gemcitabine—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Ethionamide—Headache—Gemcitabine—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Ethionamide—Vomiting—Fluorouracil—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Ethionamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Ethionamide—Hepatitis—Doxorubicin—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Ethionamide—Rash—Fluorouracil—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Ethionamide—Dermatitis—Fluorouracil—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Ethionamide—Decreased appetite—Docetaxel—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Ethionamide—Headache—Fluorouracil—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Ethionamide—Nausea—Irinotecan—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Ethionamide—Nausea—Gemcitabine—pancreatic cancer	0.00255	0.00255	CcSEcCtD
Ethionamide—Nausea—Fluorouracil—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Ethionamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Ethionamide—Dysgeusia—Epirubicin—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Ethionamide—Abdominal pain—Docetaxel—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Ethionamide—Vision blurred—Epirubicin—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Ethionamide—Agitation—Epirubicin—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Ethionamide—Dysgeusia—Doxorubicin—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Ethionamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Ethionamide—Vision blurred—Doxorubicin—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Ethionamide—Agitation—Doxorubicin—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Ethionamide—Diarrhoea—Docetaxel—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Ethionamide—Dizziness—Docetaxel—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ethionamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Ethionamide—Anorexia—Epirubicin—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Ethionamide—Vomiting—Docetaxel—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Ethionamide—Rash—Docetaxel—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Ethionamide—Dermatitis—Docetaxel—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Ethionamide—Headache—Docetaxel—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Ethionamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Ethionamide—Somnolence—Epirubicin—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Ethionamide—Anorexia—Doxorubicin—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Ethionamide—Nausea—Docetaxel—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Ethionamide—Dyspepsia—Epirubicin—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Ethionamide—Decreased appetite—Epirubicin—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Ethionamide—Somnolence—Doxorubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Ethionamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Ethionamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Ethionamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Ethionamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Ethionamide—Abdominal pain—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Ethionamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Ethionamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Ethionamide—Abdominal pain—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Ethionamide—Diarrhoea—Epirubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Ethionamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Ethionamide—Dizziness—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Ethionamide—Vomiting—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Ethionamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Ethionamide—Rash—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Ethionamide—Dermatitis—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Ethionamide—Headache—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Ethionamide—Dizziness—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Ethionamide—Nausea—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Ethionamide—Vomiting—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Ethionamide—Rash—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Ethionamide—Dermatitis—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Ethionamide—Headache—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Ethionamide—Nausea—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
